IPP Bureau
BSV invests in solar power project as part of it sustainability commitment
By IPP Bureau - March 16, 2022
This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years
I Peace triples GMP cell manufacturing by expanding CDMO facility
By IPP Bureau - March 15, 2022
The facility registration, along with DMF registration and GMP certification provides peace of mind to clients looking to use our iPSCs for clinical and commercial use in the United States, Japan, and other global markets
NuclixBio and PharmAbcine sign collaborative research agreement
By IPP Bureau - March 15, 2022
Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA’ to develop novel mRNA therapeutics that can generate PharmAbcine's antibodies
USFDA grants Orphan Drug Designation for Akantior
By IPP Bureau - March 15, 2022
SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets
Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation
By IPP Bureau - March 15, 2022
Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder
Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments
By IPP Bureau - March 15, 2022
Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023
Srichakra receives European Food Safety approval for its food-grade recycled rPET
By IPP Bureau - March 15, 2022
Srichakra receives European Food Safety approval for its food-grade recycled rPET
Uniphore and SpinSci join hands to improve patient access and engagement
By IPP Bureau - March 15, 2022
Deploying solutions like Uniphore’s U-Self Serve and U-Assist with SpinSci’s Patient Engage and Patient Assist is an important step forward in creating frictionless patient experiences
Granules Pharmaceuticals clears USFDA audit
By IPP Bureau - March 15, 2022
This is the sixth successful USFDA audit for this facility
Live Pharma Coalition to organise its first-ever conclave in Mumbai
By IPP Bureau - March 15, 2022
The focus is to build collaborative learning and sharing ecosystem
IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster
By IPP Bureau - March 15, 2022
He has over 25 years of rich experience in marketing and business in various sectors
UST launches new digital patient engagement solution in partnership with Well-Beat
By IPP Bureau - March 15, 2022
The new solution, built on patented blockchain technology, dynamically adapts to patients' behaviour patterns to make clinical encounters more effective
Exergen Medical expands presence in India
By IPP Bureau - March 15, 2022
The TAT-5000 and the TAT-2000 thermometers for professional use by doctors and nurses and the TAT-2000C thermometer for consumer applications are based on a very innovative infrared technology
Illumina unveils pathbreaking genomic profiling test for cancer in Europe
By IPP Bureau - March 15, 2022
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals
By IPP Bureau - March 15, 2022
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
